Literature DB >> 10879635

Metastatic complications of Staphylococcus aureus septicemia. To seek is to find.

H Ringberg1, A Thorén, B Lilja.   

Abstract

Improvement in the high mortality from Staphylococcus aureus septicemia must address the individualized treatment (surgery and/or prolonged antibiotic treatment) of metastatic complications. The aim of this study was to evaluate the results of a comprehensive diagnostic monitoring for metastatic complications in S. aureus septicemia. 68 consecutive patients with S. aureus septicemia were prospectively followed. The performance rate and results of chest X-ray, echocardiography, bone scintigraphy and leukocyte scintigraphy are described. Metastatic complications were found in 53% of the 68 patients, endocarditis in 26%. Positive findings resulted in surgical intervention in 23 patients. The total mortality defined as all deaths within 12 weeks was 24%; 81% of the deceased were > or = 60 years of age. Non-endocarditis patients with peripheral septic metastases had good prognosis. An active monitoring for metastatic complications in S. aureus septicemia is a necessary prerequisite for optimizing treatment and to improve survival rate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879635     DOI: 10.1007/s150100050065

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

Authors:  G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-25       Impact factor: 3.267

2.  A retrospective study (2001-2017) of acute and chronic morbidity and mortality associated with Staphylococcus aureus bacteraemia in a tertiary neonatal intensive care unit.

Authors:  Daniel O'Reilly; Ciara O'Connor; Naomi McCallion; Richard J Drew
Journal:  Ir J Med Sci       Date:  2019-02-25       Impact factor: 1.568

3.  Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implications.

Authors:  Jesper Smit; Siegbert R Rieg; Andreas F Wendel; Winfried V Kern; Harald Seifert; Henrik C Schønheyder; Achim J Kaasch
Journal:  Infection       Date:  2018-06-14       Impact factor: 3.553

4.  Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.

Authors:  E Forsblom; I Tielinen; E Ruotsalainen; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-23       Impact factor: 3.267

5.  Metastatic MSSA infection of the spine and extremities.

Authors:  Yoshihiro Katsuura; Brandon Cincere; Garrick Cason; James Osborn
Journal:  BMJ Case Rep       Date:  2018-03-05

Review 6.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia.

Authors:  James Price; Gillian Baker; Ian Heath; Karen Walker-Bone; Marc Cubbon; Sally Curtis; Mark C Enright; Jodi Lindsay; John Paul; Martin Llewelyn
Journal:  Int J Microbiol       Date:  2010-03-16

8.  Bacteraemia due to Staphylococcus aureus.

Authors:  S Ladhani; O S Konana; S Mwarumba; M C English
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

9.  Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients.

Authors:  Eeva Ruotsalainen; Kari Sammalkorpi; Janne Laine; Kaisa Huotari; Seppo Sarna; Ville Valtonen; Asko Järvinen
Journal:  BMC Infect Dis       Date:  2006-09-11       Impact factor: 3.090

10.  Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.

Authors:  Erik Forsblom; Eeva Ruotsalainen; Asko Järvinen
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.